IPRIPR2026-00149Institution Denied
Sarepta Therapeutics, Inc. et al.v.Genzyme Corporation et al.
IPR challenge of US 12013326.
Type
IPR
Filed
Nov 25, 2025
Instituted
May 6, 2026
Decided
May 6, 2026
Patent
Application
18506853
Inventor
Catherine R. O'RIORDAN et al
Granted
Jun 18, 2024
01
Timeline
3 milestones
2025-11-25Petition filed
2026-05-06Institution
2026-05-06Terminated
02
Parties & counsel
Petitioner
Sarepta Therapeutics, Inc. et al.
Counsel
Wilson, Robertet al
Patent Owner
Genzyme Corporation et al.
Counsel
Antons, Amandaet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →